ZNF711

protein-coding

zinc finger protein 711, the group of Zinc fingers C2H2-type

Gene summary

This gene encodes a zinc finger protein of unknown function. It bears similarity to a zinc finger protein which acts as a transcriptional activator. This gene lies in a region of the X chromosome which has been associated with cognitive disability. [provided by RefSeq, Jul 2008]

Previous symbols:
  • ZNF6
  • MRX65

MANE transcript

NM_001330574.2

Inheritance

XL

ClinVar variants

P:17U:203B:32

Top phenotype

Intellectual developmental disorder, X-linked 97

gnomAD constraint

pLI —, LoF o/e 0.1

Max pathogenic AF

—

Genomic locus

chrX:85,243,991-85,273,362

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~29.4 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

non-syndromic X-linked intellectual disabilitySUPPORTIVE

Inheritance Pattern: XL

Disease ID:MONDO:0019181

Submitter: Orphanet

intellectual developmental disorder, X-linked 97DEFINITIVE

Inheritance Pattern: XL

Disease ID:MONDO:0010430

Submitter: G2P

X-linked complex neurodevelopmental disorderDEFINITIVE

Inheritance Pattern: XL

Disease ID:MONDO:0100148

Submitter: ClinGen

*ZNF711* was first reported in relation to X-linked complex neurodevelopmental disorder (NDD) in 2009 by Tarpey et al. (PMID: 19377476) who reported a frameshift and nonsense variant transmitted within two large pedigrees with several affected males with intellectual disability and no other observable phenotypes. van der Werf et al. (2017, PMID: 27993705) reported two multigenerational families with X-linked complex NDD segregating with *ZNF711* variants (frameshift and missense). Four additional *ZNF711* variants were reported by Wang et al. (2022, PMID: 34992252); 3 nonsense variants and one *de novo* missense variant observed in families or individual probands affected by X-linked complex NDD. Segregation evidence from Tarpey et al. (2009), van der Werf et al. (2017), and Wang et al. (2022) resulted in 3 additional points. The maximum score for genetic evidence (12 points) was reached. Of note, missense variants in individual probands were of unclear pathogenicity and were not scored (PMIDs: 25649377, 28135719). An additional novel variant (c.127_129delGTT, p.V43del, GRCh37/hg19; ClinVar SCV:002030756.1) has been identified in a family affected by X-linked complex NDD enrolled in the Brain Gene Registry, but was not scored at this time. Experimental evidence implicates *ZNF711* in a regulatory network of syntenic, X-linked neurodevelopmental disorder-associated genes (*KDM5C, ARX, PHF8*) based on a series of studies demonstrating spatiotemporal expression patterns in developing human and mouse brains (PMID: 34356104), protein interactions (PMID: 31691806, PMID: 20346720), functional alteration in patient-derived cells (PMID: 34356104), and rescue experiments in cell culture models (PMID: 34356104 , PMID: 31691806) that are consistent with observed clinical phenotypes. In summary, there is definitive evidence supporting the relationship between *ZNF711* and X-linked complex neurodevelopmental disorder. This gene-disease pair was originally evaluated by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on November 3, 2020. It was reevaluated on September 22, 2022 (SOP Version 9). As a result of this reevaluation, the classification increased from Moderate to Definitive with the addition of new cases and experimental evidence.

intellectual developmental disorder, X-linked 97STRONG

Inheritance Pattern: XL

Disease ID:MONDO:0010430

Submitter: Ambry Genetics

intellectual developmental disorder, X-linked 97STRONG

Inheritance Pattern: XL

Disease ID:MONDO:0010430

Submitter: PanelApp Australia

intellectual developmental disorder, X-linked 97STRONG

Inheritance Pattern: XL

Disease ID:MONDO:0010430

Submitter: Labcorp Genetics (formerly Invitae)

Clinical Genomic Database (CGD)

Intellectual developmental disorder, X-linked 97XL

Manifestation: Neurologic

Intervention: General

Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing

Refs: 19377476Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to ZNF711 variants in ClinVar

9 Conditions Cataloged
not providedTotal: 103
Inborn genetic diseasesTotal: 56
Intellectual disability, X-linked 97Total: 41
not specifiedTotal: 27
ZNF711-related disorderTotal: 9
History of neurodevelopmental disorderTotal: 1
Inherited obesityTotal: 1
Intellectual disabilityTotal: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_001330574.2. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
19
clinvar
15
clinvar
2
clinvar
36
missense
1
clinvar
169
clinvar
14
clinvar
1
clinvar
185
nonsense
2
clinvar
3
clinvar
4
clinvar
9
start loss
0
frameshift
5
clinvar
6
clinvar
2
clinvar
13
splice donor/acceptor (+/-2bp)
9
clinvar
9
Total710203293252

Highest pathogenic variant AF is 9.1150474e-7

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 90 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_001330574.2RefSeqNP_001317503.18MANE Select
ENST00000674551.1EnsemblENSP00000502839.18MANE Select
NM_001375431.1RefSeqNP_001362360.18Standard
NM_001375432.1RefSeqNP_001362361.18Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Gene expression (Transcription)
  • Generic Transcription Pathway
  • RNA Polymerase II Transcription

Biological Process

  • regulation of transcription by RNA polymerase II
  • positive regulation of transcription, DNA-templated

Molecular Function

  • RNA polymerase II regulatory region sequence-specific DNA binding
  • DNA-binding transcription factor activity, RNA polymerase II-specific
  • DNA-binding transcription factor activity
  • protein binding
  • chromatin DNA binding

Cellular Component

  • nucleus

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000373165
Coding exons
7
Length
29372
Individuals with no LoFs
125346
Homozygous LoFs
1
Heterozygous LoFs
0
Defined
125347
p
0.00000399
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense2.401652780.5940.00001945089
Missense (PolyPhen)46129.920.354062496
Synonymous0.2479598.10.9680.000007221361
Loss of Function3.80220.60.09700.00000174386

Population LoF Frequency

PopulationCAFp-valueStatus
African00.0absent
Latino/Admixed American00.0absent
Ashkenazi Jewish00.0absent
East Asian00.0absent
Finnish00.0absent
European (Non-Finnish)0.0000120.0000088rare
South Asian00.0absent
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Transcription regulator required for brain development. Probably acts as a transcription factor that binds to the promoter of target genes and recruits PHF8 histone demethylase, leading to activate expression of genes involved in neuron development, such as KDM5C. {ECO:0000269|PubMed:20346720}.;

Recessive Scores

pRec
0.105

Intolerance Scores

RVIS EVS
-0.23
RVIS percentile EVS
37.11

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
E
Indispensability score
0.698

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.